Big Pharma has been accused of being a bureaucratic behemoth that’s too slow to adapt to the scientific and market realities of the 21st century. Several big industry players are responding by … wait for it … adding a new layer of high-level executives, the WSJ reports.
J&J, not often accused of running too lean, added [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment